BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 19465693)

  • 1. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
    Chung DJ; Rossi M; Romano E; Ghith J; Yuan J; Munn DH; Young JW
    Blood; 2009 Jul; 114(3):555-63. PubMed ID: 19465693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
    Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
    Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.
    Curran TA; Jalili RB; Farrokhi A; Ghahary A
    Immunobiology; 2014 Jan; 219(1):17-24. PubMed ID: 23891282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic Mature Human Dendritic Cells Generate Superior Alloreactive Regulatory T Cells in the Presence of IL-15.
    Litjens NH; Boer K; Zuijderwijk JM; Klepper M; Peeters AM; Prens EP; Verschoor W; Kraaijeveld R; Ozgur Z; van den Hout-van Vroonhoven MC; van IJcken WF; Baan CC; Betjes MG
    J Immunol; 2015 Jun; 194(11):5282-93. PubMed ID: 25917092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
    Sharma MD; Baban B; Chandler P; Hou DY; Singh N; Yagita H; Azuma M; Blazar BR; Mellor AL; Munn DH
    J Clin Invest; 2007 Sep; 117(9):2570-82. PubMed ID: 17710230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?
    Terness P; Chuang JJ; Bauer T; Jiga L; Opelz G
    Blood; 2005 Mar; 105(6):2480-6. PubMed ID: 15572592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO.
    Krause P; Singer E; Darley PI; Klebensberger J; Groettrup M; Legler DF
    J Leukoc Biol; 2007 Nov; 82(5):1106-14. PubMed ID: 17698915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells.
    Jürgens B; Hainz U; Fuchs D; Felzmann T; Heitger A
    Blood; 2009 Oct; 114(15):3235-43. PubMed ID: 19625705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologic control of IDO competence in splenic dendritic cells.
    Baban B; Chandler PR; Johnson BA; Huang L; Li M; Sharpe ML; Francisco LM; Sharpe AH; Blazar BR; Munn DH; Mellor AL
    J Immunol; 2011 Sep; 187(5):2329-35. PubMed ID: 21813777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct tolerogenic subset of splenic IDO(+)CD11b(+) dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis.
    Park MJ; Park KS; Park HS; Cho ML; Hwang SY; Min SY; Park MK; Park SH; Kim HY
    Cell Immunol; 2012; 278(1-2):45-54. PubMed ID: 23121975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.
    Chen W; Liang X; Peterson AJ; Munn DH; Blazar BR
    J Immunol; 2008 Oct; 181(8):5396-404. PubMed ID: 18832696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.
    Park MJ; Min SY; Park KS; Cho YG; Cho ML; Jung YO; Park HS; Chang SH; Cho SG; Min JK; Park SH; Kim HY
    Arthritis Res Ther; 2008; 10(1):R11. PubMed ID: 18221522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.
    Kahler DJ; Mellor AL
    Handb Exp Pharmacol; 2009; (188):165-96. PubMed ID: 19031026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.
    Hill M; Tanguy-Royer S; Royer P; Chauveau C; Asghar K; Tesson L; Lavainne F; Rémy S; Brion R; Hubert FX; Heslan M; Rimbert M; Berthelot L; Moffett JR; Josien R; Grégoire M; Anegon I
    Eur J Immunol; 2007 Nov; 37(11):3054-62. PubMed ID: 17948274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.
    Sun J; Yu J; Li H; Yang L; Wei F; Yu W; Liu J; Ren X
    J Exp Clin Cancer Res; 2011 Sep; 30(1):82. PubMed ID: 21917155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
    Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
    Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
    Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
    Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
    Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
    Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of kidney allograft survival regulated by indoleamine 2, 3-dioxygenase in immature dendritic cells generated from recipient type bone marrow progenitors.
    Na N; Luo Y; Zhao D; Yang S; Hong L; Li H; Miao B; Qiu J
    Mol Immunol; 2016 Nov; 79():22-31. PubMed ID: 27689750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.